Applications Published 2 November 2000
Published: 25-Jun-2001
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Inhibition of RAF kinase using substituted heterocyclic ureas
Bayer 1047418*Methods for treating diabetic dyslipidaemia using tocopherols
Lipogenics 1047419*Modulation of hair growth
Handelman, Joseph 1047420*Inhibition of lipoprotein oxidation
Warner-Lambert 1047421*Use of histamine for elevating blood histamine levels
Maxim Pharmaceuticals 1047422*Novel apoptosis inhibitors
Takeda Chemical Industries 1047423*IL-8 receptor antagonists
SmithKline Beecham 1047424*Integrin receptor antagonists
Merck 1047425*Use of methylnaltrexone and related compounds
Arch Development 1047426*Combination of a GABA-A alpha 2/3 agonist and a selective serotonin reuptake inhibitor
Merck Sharpe and Dohme 1047427*Pharmaceutically active morpholinol
Glaxo Group 1047428*The use of brinzolamide to prevent visual field loss
Alcon Laboratories 1047429*A gel-form pharmaceutical preparation
Leiras 1047430*Pharmaceutically active compounds and methods of use thereof
Trustees of Tufts College 1047431*Drug-directed mutogenesis/drug-driven selection for lethal mutants
Visible Genetics 1047432*Cellulose derivatives and colorectal cancer risk detection
SmithKline Beecham 1047433*Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
Knoll 1047434*Use of an aqueous solution in the preparation of a medicament for use in the treatment of live animals
Radical Waters; Hinze, Gilbert 1047435*Methods of treating tardive dyskinesia and other movement disorders
Synchroneuron 1047436*Sea cucumber carotenoid lipid fraction products and methods of use
Collin, Peter Donald 1047437*A process for the isolation, recovery and purification of non-polar extractives.
Her Majesty in right of Canada, represented by her Minister of Agriculture and Agri-Food Canada 1047438*
Pharmaceutical compsns and method of using same
Xu, Kai Jian 1047439*St John's Wort and methyl donor compsn, and uses thereof
Rexall Sundown 1047440*Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
University of Southern California 1047441*Bone morphgenetic proteins and their use in bone growth.
Nimni, Marcel; Hall, Frederick; Wu, Lingtao; Han, Bo; Shors, Edwin 1047442*Methods and compsns for enhancing cognitive function using morphogenic proteins
Creative Biomolecules 1047443*Methods of neuroendocrine regulation of affective disorders
Beth Israel Deaconess Centre; Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services 1047444*Modified enzymes and their use for peptide synthesis
Genencor International 1047445*Vaccine compsn for herpes simplex virus and methods of using
University of Maryland 1047446*Lipooligosaccharide-based vaccine for prevention of Moraxella branhamella catarrhalis infections in animals
The United States Government as represented by the Department of Health and Human Services 1047447*DNA vaccines against tick-borne flavi-viruses
United States Army Medical Research and Materiel Command 1047448*Immunological compsns and methods of use to transiently altyer mammalian central nervous system myelin to promote neuronal regeneration
University of British Columbia 1047449*ACE inhibitor-MMP inhibitor combinations
Warner-Lambert 1047450*Use of heat shock proteins to deliver moieties into cells
Whitehead Institute for Biomedical Research 1047451*Conjugates comprising two active agents
Quadrant Healthcare 1047452*Method for determining gene essentiality in a pathogen
SmithKline Beecham 1047453*Methods for screening compounds useful for prevention of infection or pathogenicity
The General Hospital Corporation; The Netherlands Cancer Institute 1047454*A method and compsn for cancer treatment by enzymatic conversion of soluble radioactive toxic agent
Rose, Samuel 1047456*Use of radiolabeled monoclonal IGM in treatment for cancer and autoimmune disease
MCA Development; Borchardt, Paul; Vriesendorp, Huebert; Quadri, Syed 1047457*Method for inactivation of microorganisms using photosensitisers
Gambro 1047458*Alkenyldiarylmethane non-nucleoside HIV-1 reverse transcriptase inhibitors
Purdue Research Foundation; The United States of America as represented by the Secretary of the Department of Health and Human Services 1047656*Novel tricyclic compounds, preparation method and pharmaceutical compsns containing same
Adir et Compagnie 1047664*Matrix metalloprotease inhibitors
Pfizer 1047665*Novel process for preparing a ketimine
Pfizer 1047666*Preparation of N-phenyl-benzoquinoneimine from hydroxydiphenylamines
Flexsys America 1047667*Triazepinones, process for their preparation and their therapeutic application
Merck Patent 1047668*Perfluoro-N-alkylsulphonic acid derivatives
Merck Patent 1047669*Aminosulphonylnenzamide derivatives as modulators of the activity of neuronal calcium channels
Eli Lilly 1047670*Method of preparation of cholecalciferol derivatives and new intermediate compounds
Instytut Farmaceutucyny 1047671*Novel heterocyclic compounds
Novo Nordisk 1047673*Process for the production of donepezil derivatives
Eisai 1047674*Chemokine receptor antagonists and methods of use therefor
Millennium Pharmaceutical; Kyowa Hakko Kogyo 1047675*Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterised by abnormal cell proliferation
President and Fellows of Harvard College; Children's Medical Centre Corp; Nuchem Pharmaceuticals 1047676*1,4,7,10-tetraazacylcododecane-1m4-diacetic acid derivatives as chelating agents
Bracco 1047677*1-substituted-1-aminomethyl-cycloalkane derivatives (gabapentin analogues), their preparation and use in the treatment of neurological disorders
Warner-Lambert 1047678*Thioether furn nitrone compounds
Centaur Pharmaceuticals 1047683*
